Clinical Trials Logo

Osgood-Schlatter Disease clinical trials

View clinical trials related to Osgood-Schlatter Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT05826340 Recruiting - Clinical trials for Osgood-Schlatter Disease

Getting Kids With Osgood Schlatter Back to Performing Without Pain

QUICKRETURNOSD
Start date: January 26, 2023
Phase: N/A
Study type: Interventional

The goal of this trial is to compare graded return to sport, or pain guided activity to rest in youth with Osgood Schlatter. The main objectives are: - to assess the graded return to sport, or pain guided activity on symptoms (pain and function) at six months compared to rest The secondary objectives are to assess the impact of progressive return to sport or pain guided activity on: - Muscle strength and performance - Anterior knee pain provocation - Sports participation - Physical activity The exploratory objectives are to assess the impact of progressive return to sport on ultrasound imaging characteristics of OSD.

NCT ID: NCT05789095 Completed - Clinical trials for Osgood-Schlatter Disease

Rate of Torque Development in Adolescents With Osgood-Schlatter

Start date: February 28, 2023
Phase:
Study type: Observational

Osgood-Schlatter is a growth-related condition involving multiple different types of tissue in the tendon-bone interface at the tibial tubercle. Osgood-Schlatter affects one in ten adolescents causing persistent pain and reduced ability to maintain physical activities. Changes in rate of torque development is associated with decreased neuromuscular functioning and pain chronicity, thereby affecting athletic performances and general physical activities. However, changes in rate of torque development has not been investigate in patients with Osgood-Schlatter and could help characterize the condition and guide management. The aim of the study is to investigate early and peak rate of torque development during maximal voluntary isometric knee extension and knee flexion in adolescents with Osgood-Schlatter, compared to a matched group of asymptomatic adolescents (controls), in a cross-sectional study. The study will include 13 adolescent participants with Osgood-Schlatter and a group of 13 pain free controls matched on sex, age, and sports participation on the group level. Testing will include rate of torque measurements of knee extension and flexion for each limb with a fixated handheld dynamometer during a single test-session lasting approximately two hours. The examiner responsible for strength-testing will be blinded to case-status. Along with anthropometric data, participants will perform the anterior knee pain provocation test to assess pain-response to sustained knee loading, a countermovement jump test to assess power and jump height, and provide patient-reported measures of condition severity, pain, disability, and quality of life. Data collection will start March 2023 and is expected to finish by May 2023.

NCT ID: NCT05174182 Active, not recruiting - Clinical trials for Osgood-Schlatter Disease

A Comparison of Two Different Treatment Approaches for Adolescents With Osgood Schlatter

SOGOOD
Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The most common growth-related injury is Osgood Schlatter, which affects up to 1 in 5 physically active adolescents. It can cause long-term pain and potential discontinuation of sports and physical activity, with sequela well into adulthood. No effective conservative treatments have been documented, and clinical practice is characterized by a wealth of conflicting advice and modalities. A novel treatment approach has shown promising results in a small single-cohort study. Therefore, this study aims to compare this novel treatment with usual care in 10-16-year-old adolescents with Osgood Schlatter. This single-center pragmatic, double-blinded, randomized, controlled superiority trial, will have a two-group parallel arm design. Participants will undergo 3 months of treatment, followed by 2 months of self-management with self-reported knee function (KOOS-child 'Sport/rec') at 5 months as the primary endpoint. This trial comparing a novel treatment with usual care for adolescents with Osgood Schlatter could result in an evidence-based treatment ready for implementation in clinical practice, benefitting patients outcomes and clinicians.

NCT ID: NCT04716608 Completed - Clinical trials for Osgood-Schlatter Disease

Treatment for Osgood Schlatter Patients With a Physiotherapy Program

TrOPhy
Start date: November 11, 2020
Phase: N/A
Study type: Interventional

This study is to compare the effect of a physiotherapy program to usual care treatment in patients with Osgood Schlatter disease (OSD). Patients will be randomly assigned into two groups. Group 1 will receive the physiotherapy program with myofascial massage, while group 2 (usual care group USC) will receive usual care treatment.

NCT ID: NCT03589001 Completed - Clinical trials for Osgood-Schlatter Disease

24 Month Follow-up of Patients With Osgood Schlatter (OSD)

Start date: July 10, 2018
Phase:
Study type: Observational

Osgood Schlatter is a common knee condition, affecting approximately 10% of adolescents. OSD is thought to be a growth related pain conditon, and thus resolve after maturation. Despite this, there a lack of prospective data investigating whether this is in fact the case.

NCT ID: NCT02824172 Completed - Clinical trials for Osgood Schlatter Disease

Treatment of the Osgood Schlatter

OSGOOD
Start date: September 2015
Phase: N/A
Study type: Interventional

The disease Osgood-Schlatter is most commonly found in sports teenager growing up apophysose accounting for 28.4% of osteochondrosis by Breck. It relates to 62% of osteochondrosis knee and affects adolescent girls between 10 and 12 and boys between 12 and 15 It is usually considered a benign pathology that cures in the majority of cases. However, in 5-10% of cases there is persistent residual pain in adulthood. The classic complication is the avulsion fracture of the tibial tuberosity in adolescents who continued his sports without restriction. The possible consequences are numerous including the presence of a free bone fragment at the insertion of the tendon originally described by Osgood the establishment of a genu recurvatum, a high kneecap or patella alta and an enlarged tibial tuberosity (ATT) annoying sport. The main two treatments are complete rest from sport activity or cast immobilization. The main objective is to compare these two technics according to the proportion of full sporting recovering at 12 months

NCT ID: NCT02799394 Completed - Clinical trials for Osgood Schlatter Disease

Effect of Activity Modification and Exercises in Young Adolescents With Osgood Schlatter Disease.

Start date: June 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect of activity modification, exercises and a gradual return to sport in adolescents (age 10-14) with Osgood Schlatter disease. The primary outcome is self-reported recovery on a 7-point Likert scale at 3 months. Secondary endpoints include 4 and 8 weeks and 6 and 12 months after inclusion into the project. The adolescents will be recruited from primary schools, general practitioners and through online advertising on Facebook.

NCT ID: NCT01300754 Completed - Clinical trials for Osgood-Schlatter Disease

Effectiveness of Dextrose Injection for Osgood-Schlatter Disease

Start date: January 2006
Phase: Phase 1/Phase 2
Study type: Interventional

Objective: To examine the potential of dextrose injection versus lidocaine injection versus supervised usual care to change pain/function/activity levels in adolescent athletes with Osgood-Schlatter Disease (OSD).